Thromb Haemost 1990; 64(03): 485
DOI: 10.1055/s-0038-1647341
Letter to the Editor
Schattauer GmbH Stuttgart

Effest of Molsidomine on t-PA and PAI Activity in Man: A Double Blind, Placebo Controlled Study

Lilia Grodzinska
*   Copernikus Medical Academy 31-531 Krakow, Poland
,
Gerd Hafner
II. Medizinische Klinik Johannes- Gutenberg-Universitat 6500 Mainz 1, FR Germany
,
Harald Darius
II. Medizinische Klinik Johannes- Gutenberg-Universitat 6500 Mainz 1, FR Germany
,
II Medizinische Klinik
II. Medizinische Klinik Johannes- Gutenberg-Universitat 6500 Mainz 1, FR Germany
› Author Affiliations
Further Information

Publication History

Received 05 April 1990

Accepted after revision 11 June 1990

Publication Date:
25 July 2018 (online)

 
  • References

  • 1 Feelisch M, Noack EA. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol 1987; 139: 19-30
  • 2 Darius H, Ahland B, Rücker W, Klaus W, Peskar BA, Schror K. The effects of molsidomine and its metabolite SIN-I on coronary vessel tone, platelet aggregation, and eicosanoid formation in vitro - inhibition of 12-HPETE biosynthesis. J Cardiovasc Pharmacol 1985; 6: 115-121
  • 3 Grodzinska L, Basista M, Swies J. Molsidomine and its metabolite SIN-I. Fibrinolytic and disaggregating properties. In: Prostaglandins and Other Eicosanoids in the Cardiovascular System Schror K. (ed). Karger, Basel: 1985: 509-512
  • 4 Klocking HP, Hoffmann A, Markwardt F. Release of plasminogen activator by molsidomine and its active metabolite SIN-I. Pharmazie 1987; 42: 354